AQB logo

AquaBounty Technologies, Inc. (AQB)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

AquaBounty Technologies, Inc. (AQB) trades at $0.94 with AI Score 53/100 (Hold). AquaBounty Technologies, Inc. focuses on enhancing productivity in the aquaculture industry through genetic research and development. Market cap: 4M, Sector: Consumer defensive.

Last analyzed: Mar 3, 2026
AquaBounty Technologies, Inc. focuses on enhancing productivity in the aquaculture industry through genetic research and development. Their primary product is AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption, aimed at improving efficiency and sustainability in salmon farming.
53/100 AI Score MCap 4M Vol 49K

AquaBounty Technologies, Inc. (AQB) Consumer Business Overview

AquaBounty Technologies pioneers sustainable aquaculture with its AquAdvantage Salmon, a bioengineered solution poised to revolutionize salmon production, addressing growing demand while minimizing environmental impact, positioning the company for significant growth in the evolving food technology landscape.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Mar 3, 2026

Investment Thesis

Investing in AquaBounty Technologies presents a unique opportunity to capitalize on the growing demand for sustainable protein sources and advancements in aquaculture technology. The company's AquAdvantage Salmon offers a compelling value proposition by reducing the time to market and potentially lowering production costs compared to traditional salmon farming. With a gross margin of 100.0%, AquaBounty demonstrates the potential for high profitability as production scales. Key catalysts include expanding production capacity and securing additional regulatory approvals in key markets. The company's focus on genetic research and development positions it at the forefront of aquaculture innovation. As AquaBounty successfully scales its operations and gains wider market acceptance for its AquAdvantage Salmon, the stock offers significant upside potential. The high beta of 1.32 suggests higher volatility, which could translate to outsized gains if the company executes its growth strategy effectively.

Based on FMP financials and quantitative analysis

Key Highlights

  • Gross Margin of 100.0% indicates strong potential profitability as production scales.
  • Profit Margin of 12544.1% reflects the impact of fair value adjustments on biological assets.
  • Beta of 1.32 suggests higher volatility compared to the market.
  • Focus on AquAdvantage Salmon positions the company to capitalize on the growing demand for sustainable protein.
  • Genetic research and development activities drive innovation in the aquaculture industry.

Competitors & Peers

Strengths

  • Innovative AquAdvantage Salmon technology.
  • High gross margin potential.
  • First-mover advantage in the GE salmon market.
  • Strong focus on sustainability.

Weaknesses

  • Limited production capacity.
  • Dependence on regulatory approvals.
  • Small number of employees.
  • Public perception concerns regarding genetically engineered food.

Catalysts

  • Ongoing: Expansion of production capacity at existing facilities.
  • Ongoing: Pursuit of regulatory approvals in new markets.
  • Ongoing: Strategic partnerships with food retailers and distributors.
  • Upcoming: Potential for positive earnings surprises as production scales.

Risks

  • Potential: Regulatory delays or denials in key markets.
  • Ongoing: Negative consumer perception of genetically engineered food.
  • Potential: Competition from traditional salmon farms.
  • Ongoing: Dependence on a single product (AquAdvantage Salmon).
  • Ongoing: Dilution risk due to the need for additional capital to fund expansion.

Growth Opportunities

  • Expansion of Production Capacity: AquaBounty can significantly increase its revenue by expanding its production facilities. Investing in larger, more efficient farms will allow the company to meet growing demand for AquAdvantage Salmon. The global salmon market is estimated to be worth billions of dollars, providing a substantial opportunity for AquaBounty to capture a larger market share. Timeline: Ongoing.
  • Securing Regulatory Approvals in New Markets: Obtaining regulatory approvals in key markets, such as Europe and Asia, will open up new avenues for growth. These markets represent a significant portion of global salmon consumption. Successful navigation of regulatory processes will be crucial for AquaBounty's international expansion. Timeline: Ongoing.
  • Strategic Partnerships and Distribution Agreements: Forming strategic partnerships with major food retailers and distributors will enhance AquaBounty's market reach and brand recognition. Collaborations with established players in the food industry will facilitate the distribution and sale of AquAdvantage Salmon. Timeline: Ongoing.
  • Development of New Genetically Engineered Products: AquaBounty can leverage its expertise in genetic engineering to develop new products for the aquaculture industry. This could include genetically enhanced versions of other commercially important fish species. Diversifying its product portfolio will reduce the company's reliance on a single product. Timeline: Ongoing.
  • Licensing of AquAdvantage Technology: Licensing its AquAdvantage technology to other aquaculture companies can generate a recurring revenue stream for AquaBounty. This would allow the company to capitalize on its intellectual property without directly investing in additional production facilities. Timeline: Ongoing.

Opportunities

  • Expansion into new geographic markets.
  • Strategic partnerships with food retailers.
  • Development of new genetically engineered products.
  • Licensing of AquAdvantage technology.

Threats

  • Competition from traditional salmon farms.
  • Regulatory hurdles and delays.
  • Negative consumer perception of GE food.
  • Potential for environmental concerns related to aquaculture.

Competitive Advantages

  • Proprietary AquAdvantage technology protected by patents.
  • First-mover advantage in the genetically engineered salmon market.
  • Specialized expertise in aquaculture and genetic engineering.
  • Regulatory approvals for AquAdvantage Salmon in key markets.

About AQB

AquaBounty Technologies, Inc., established in 1991 and headquartered in Maynard, Massachusetts, is a biotechnology company dedicated to improving productivity in the commercial aquaculture industry. Originally named Aqua Bounty Farms, Inc., the company rebranded in 2004 to reflect its focus on technological advancements. AquaBounty's core business revolves around genetic, genomic, and fish health and nutrition research activities. The company's flagship product is AquAdvantage Salmon, a genetically engineered Atlantic salmon designed for human consumption. This innovative product grows to market size faster than conventional Atlantic salmon, potentially reducing the environmental footprint and increasing the efficiency of salmon farming. In addition to AquAdvantage Salmon, AquaBounty sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. AquaBounty aims to address the increasing global demand for seafood while promoting sustainable aquaculture practices through its bioengineered salmon and related technologies. With a small team of 4 employees, AquaBounty is focused on scaling production and distribution of its AquAdvantage Salmon.

What They Do

  • Develops and markets AquAdvantage Salmon, a genetically engineered Atlantic salmon.
  • Conducts genetic, genomic, and fish health and nutrition research.
  • Sells conventional Atlantic salmon, salmon eggs, and fry.
  • Focuses on enhancing productivity in the commercial aquaculture industry.
  • Aims to provide a sustainable solution to meet the growing demand for seafood.
  • Utilizes biotechnology to improve the efficiency of salmon farming.

Business Model

  • Generates revenue through the sale of AquAdvantage Salmon.
  • Sells conventional Atlantic salmon, salmon eggs, and fry.
  • Focuses on research and development to improve aquaculture practices.
  • Aims to license its AquAdvantage technology to other aquaculture companies.

Industry Context

AquaBounty operates within the agricultural farm products industry, a segment of the broader consumer defensive sector. The industry is characterized by increasing demand for sustainable food production methods and innovative technologies to enhance efficiency. The competitive landscape includes traditional aquaculture farms and other biotechnology companies focused on improving crop and livestock yields. AquaBounty differentiates itself through its AquAdvantage Salmon, offering a faster growth cycle and potentially lower environmental impact. The global aquaculture market is projected to continue growing, driven by rising seafood consumption and the need for sustainable alternatives to wild-caught fish.

Key Customers

  • Food retailers and distributors.
  • Restaurants and foodservice providers.
  • Consumers seeking sustainable seafood options.
AI Confidence: 75% Updated: Mar 3, 2026

Financials

Chart & Info

AquaBounty Technologies, Inc. (AQB) stock price: $0.94 (-0.02, -2.40%)

Latest News

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AQB.

Price Targets

Wall Street price target analysis for AQB.

MoonshotScore

53/100

What does this score mean?

The MoonshotScore rates AQB's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Common Questions About AQB

What does AquaBounty Technologies, Inc. (AQB) do?

AquaBounty Technologies, Inc. is a biotechnology company focused on enhancing productivity in the aquaculture industry. Its primary product is AquAdvantage Salmon, a genetically engineered Atlantic salmon that grows to market size faster than conventional salmon. The company aims to provide a sustainable and efficient solution to meet the growing global demand for seafood by reducing the time and resources required for salmon production. AquaBounty also sells conventional Atlantic salmon, salmon eggs, and fry.

Is AQB stock worth researching?

Evaluating whether AQB stock is worth researching requires considering both its potential and risks. The company's AquAdvantage Salmon offers a unique value proposition with its faster growth cycle and high gross margin potential. However, AQB is a micro-cap stock with limited production capacity and dependence on regulatory approvals. Investors should weigh the potential for significant growth against the inherent risks associated with a small, developing company in a controversial sector. Further research into the company's financials and future plans is recommended.

What are the risks of investing in AQB?

Investing in AquaBounty (AQB) carries several risks. One major risk is regulatory uncertainty, as the company's AquAdvantage Salmon requires approvals in various markets. Negative consumer perception of genetically engineered food could also impact demand. Additionally, as a micro-cap company, AQB faces liquidity risks and the potential for stock dilution through future fundraising efforts. Competition from traditional salmon farms and potential environmental concerns related to aquaculture also pose ongoing threats to the company's success.

What catalysts could move AQB stock?

Several catalysts could positively influence AQB stock. Successful expansion of production capacity at AquaBounty's facilities would signal the company's ability to meet growing demand. Securing regulatory approvals in key international markets, such as Europe or Asia, would significantly expand the company's market reach. Positive earnings reports demonstrating increasing sales and profitability could also drive investor confidence and stock appreciation. Any strategic partnerships with major food retailers could also serve as a catalyst.

What is AQB stock price target?

As of March 3, 2026, there is no readily available analyst consensus price target for AQB stock due to its micro-cap status and limited analyst coverage. A fair value estimate would require a detailed financial model incorporating assumptions about future sales growth, production costs, and regulatory approvals. Investors should conduct their own due diligence and consider various valuation methods to determine a reasonable price target for AQB stock, considering the inherent risks and uncertainties associated with the company's business model.

What are the key factors to evaluate for AQB?

AquaBounty Technologies, Inc. (AQB) currently holds an AI score of 53/100, indicating moderate score. Key strength: Innovative AquAdvantage Salmon technology.. Primary risk to monitor: Potential: Regulatory delays or denials in key markets.. This is not financial advice.

How frequently does AQB data refresh on this page?

AQB prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven AQB's recent stock price performance?

Recent price movement in AquaBounty Technologies, Inc. (AQB) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Innovative AquAdvantage Salmon technology.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available data and may be subject to change.
  • Investment decisions should be based on individual risk tolerance and financial circumstances.
Data Sources

Popular Stocks